W81K00-26-Q-A085 Solicitation Amendment - 0002 to perform automated microbial identification and susceptibility testing for the Brooke Army Medical Center (BAMC) Department of Pathology and Area Laboratory Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
W40M MRC0 WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
W81K00-26-Q-A085
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6640
Additional Details
Documents1
The Department of the Army, through the W40M MRC0 WEST contracting office, has issued Solicitation Amendment 0002 under procurement identifier W81K00-26-Q-A085. This solicitation seeks qualified contractors to perform automated microbial identification and susceptibility testing services for the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center (BAMC), located at Joint Base San Antonio (JBSA) Ft Sam Houston, Texas.
The primary objective of this procurement is to support BAMC’s clinical laboratory operations by ensuring timely and accurate identification of microbial organisms and determination of their antimicrobial susceptibility profiles. This capability is critical for effective patient diagnosis, infection control, and the selection of appropriate therapeutic interventions within the medical center and its associated area laboratory services.
The scope of work encompasses the provision of automated systems, reagents, and related consumables necessary for in-vitro diagnostic testing, as classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and Product Service Code 6640. Contractors are expected to deliver solutions that meet the rigorous standards of clinical laboratory practice, ensuring reliability, accuracy, and compliance with applicable regulatory requirements.
Amendment 0002 to the solicitation specifically addresses responses to offeror questions received following the initial release of the solicitation on March 30, 2026. Notably, the proposal submission deadline remains unchanged, with all responses due by Monday, April 20, 2026, at 1:00 PM CST. All other terms and conditions of the original solicitation are maintained.
This opportunity is not set aside for any specific business category, allowing for full and open competition. The place of performance is exclusively at JBSA Ft Sam Houston, Texas, within the United States.
Interested contractors should note that the contracting activity is managed by the Department of Defense, Department of the Army, with the following primary points of contact for inquiries and proposal submissions:
- Medina L. Woodson ([email protected], 210-808-5753, Fax: 210-221-3446)
- Salameya Paulouskaya ([email protected], 210-539-8656, Fax: 210-221-3446)
The solicitation and its amendment, along with any attachments, can be accessed via the official SAM.gov opportunity posting (Opportunity ID: 7550db972d0944488354f02a0782257f).
Contractors evaluating this opportunity should ensure their capabilities align with the requirements for automated microbial identification and susceptibility testing in a high-throughput, clinical laboratory environment. The successful offeror will be expected to provide reliable, regulatory-compliant solutions that support BAMC’s mission of delivering high-quality healthcare services to military personnel and beneficiaries.